Cargando…
Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI
Brain volume loss, or atrophy, has been proven to be an important characteristic of neurological diseases such as Alzheimer's disease and multiple sclerosis. To use atrophy rate as a reliable clinical biomarker and to increase statistical power in clinical treatment trials, measurement variabil...
Autores principales: | Amiri, Houshang, Brouwer, Iman, Kuijer, Joost P.A., de Munck, Jan C., Barkhof, Frederik, Vrenken, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350260/ https://www.ncbi.nlm.nih.gov/pubmed/30665101 http://dx.doi.org/10.1016/j.nicl.2019.101667 |
Ejemplares similares
-
Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses
por: van Nederpelt, David R., et al.
Publicado: (2023) -
Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017) -
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
por: Amiri, Houshang, et al.
Publicado: (2018) -
Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia
por: Bartel, F., et al.
Publicado: (2019) -
The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis
por: Mattiesing, Rozemarijn M., et al.
Publicado: (2022)